Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000842291 | SCV000984298 | likely benign | not provided | 2019-10-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001081995 | SCV001002612 | likely benign | Spastic paraplegia | 2024-11-30 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000842291 | SCV001149252 | uncertain significance | not provided | 2016-05-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002536149 | SCV003686887 | likely benign | Inborn genetic diseases | 2021-10-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003965628 | SCV004777570 | likely benign | ZFYVE26-related disorder | 2023-06-16 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |